Download Files:
Products Details
Product Description
– Cap-dependent endonuclease-IN-19 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-19 is a spirocyclic pyridone derivative. Cap-dependent endonuclease-IN-19 has strong inhibitory effect on RNA polymerase activity of A virus (extracted from patent CN111410661A, compound 1)[1].
Web ID
– HY-144065
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C28H31N3O4
References
– [1]Wenteng Chen, et al. Spiropyridone derivatives and their applications. Patent CN112047945B.
CAS Number
– 2567929-06-8
Molecular Weight
– 473.56
SMILES
– O=C1C=CN2C(C(N(C3(CCCCC3)N2C(C4=CC=CC=C4)C5=CC=CC=C5)CCOC)=O)=C1O
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– Influenza Virus
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
